Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy
Theodoros Michelakos(Harvard University), Cristina R. Ferrone(Cedars-Sinai Medical Center), David T. Ting(Massachusetts General Hospital), Colin D. Weekes(Massachusetts General Hospital), Tomohiro Kurokawa(Fukushima Medical University), Soldano Ferrone(Massachusetts General Hospital), Motaz Qadan(Massachusetts General Hospital), Martin S. Taylor(Brown University), Vikram Deshpande(Beth Israel Deaconess Medical Center), Theodore S. Hong(Massachusetts General Hospital), Vincenzo Villani(Harvard University), Keith D. Lillemoe(Harvard University), Azfar Neyaz(Massachusetts General Hospital), Filippos Kontos(Harvard University), David P. Ryan(East Carolina University), Jennifer Y. Wo(Massachusetts General Hospital), Jeffrey W. Clark(Massachusetts General Hospital), Teppei Yamada(Harvard University), Lei Cai(Army Medical University), Carlos Fernández-del Castillo(Massachusetts General Hospital), Andrew L. Warshaw(Harvard University), Jill N. Allen(Harvard University), Francesco Sabbatino(University of Salerno)
Cited by 74
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k